Loading organizations...
Brain Asset Management is a prominent asset management firm in Korea, specializing in hedge funds, personal managed accounts, and investment advisory services. The company also actively operates private equity funds. Its investment approach is characterized by a robust philosophy and a strong emphasis on independent, in-depth research, underpinning its strategies across various asset classes.
Established in 2009 by President KunYung Park, the firm emerged from Park's vision to develop and lead the nascent Korean hedge fund market. As a respected fund manager, his expertise provided the crucial foundation for pioneering sophisticated investment solutions within the domestic financial sector.
Serving institutional and high-net-worth individuals, particularly via its private equity operations, Brain Asset Management aims to deliver consistent value. The firm’s enduring vision focuses on disciplined analysis and unwavering fiduciary responsibility, aspiring to be a trusted, insightful partner for clients navigating complex wealth management challenges.
Brain Asset Management has 1 tracked investment across 1 company. The latest tracked deal is $26.2M Grant / Series B in PDC*line Pharma in December 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 6, 2021 | PDC*line Pharma | $26.2M Grant / Series B | Sangwoo LEE | Alpha Holdings, Hansongneotech, Noshaq, Sambrinvest, Fontaine François, Smart Korea UTC BIO Healthcare Venture Fund, Sriw, Walloon Region |